Also trades as: TTKHEALTH.BO (BSE) · $vol 0M
TTKHLTCARE.NS NSE
TTK Healthcare Limited
1W: -3.1%
1M: -10.2%
3M: +10.9%
YTD: +7.0%
1Y: -10.4%
3Y: -12.0%
5Y: +38.5%
₹1,015.50 ($10.55)
+2.50 (+0.25%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Balance Sheet Trends
Total Assets
$13.3B
+3.7% ▲
5Y CAGR: +21.9%
Total Liabilities
$2.1B
-1.0% ▼
5Y CAGR: +1.4%
Shareholders Equity
$11.1B
+4.7% ▲
5Y CAGR: +30.5%
Cash & Investments
$9.4B
+9.5% ▲
5Y CAGR: +32.7%
Total Debt
$244M
+0.7% ▲
5Y CAGR: +5.0%
Net Debt
$25M
+100.3% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $149M | $93M | $110M | $90M | $219M |
| Short-Term Investments | $2.6B | $8.4B | $8.3B | $8.5B | $9.1B |
| Cash & ST Investments | $2.7B | $8.5B | $8.5B | $8.6B | $9.4B |
| Net Receivables | $587M | $1.1B | $271M | $1.2B | $1.5B |
| Inventory | $789M | $845M | $970M | $1.1B | $1.1B |
| Other Current Assets | $260M | $43M | $900M | $153M | $257M |
| Total Current Assets | $4.5B | $10.7B | $10.8B | $11.0B | $12.2B |
| Property, Plant & Equip. | $805M | $739M | $756M | $810M | $740M |
| Goodwill & Intangibles | $863K | $366K | $58K | $0 | $0 |
| Long-Term Investments | $151M | $141M | -$8.0B | $781M | $194M |
| Other Non-Current Assets | $70M | $116M | $8.4B | $182M | $113M |
| Total Non-Current Assets | $1.1B | $1.0B | $1.2B | $1.8B | $1.1B |
| Total Assets | $5.6B | $11.7B | $12.0B | $12.8B | $13.3B |
| — Liabilities — | |||||
| Accounts Payable | $1.0B | $1.1B | $857M | $1.1B | $913M |
| Short-Term Debt | $204M | $255M | $215M | $219M | $219M |
| Deferred Revenue | $908M | $566M | $0 | $0 | $0 |
| Other Current Liabilities | -$512M | $11M | $358M | $816M | $852M |
| Total Current Liabilities | $2.2B | $2.1B | $2.0B | $2.1B | $2.1B |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $38M | $30M | $31M | $34M | $57M |
| Total Non-Current Liabilities | $84M | $59M | $39M | $52M | $77M |
| Total Liabilities | $2.3B | $2.2B | $2.0B | $2.2B | $2.1B |
| — Equity — | |||||
| Common Stock | $141M | $141M | $141M | $141M | $141M |
| Retained Earnings | $2.0B | $8.3B | $8.7B | $9.4B | $9.9B |
| Accumulated OCI | $1.0B | $1.0B | $1.0B | $1.0B | $982M |
| Total Stockholders Equity | $3.3B | $9.5B | $10.0B | $10.7B | $11.1B |
| Total Liabilities & Equity | $5.6B | $11.7B | $12.0B | $12.8B | $13.3B |
| — Key Metrics — | |||||
| Total Debt | $222M | $273M | $228M | $242M | $244M |
| Net Debt | $73M | $180M | $119M | -$7.6B | $25M |
| Total Investments | $2.7B | $8.5B | $384M | $9.2B | $9.3B |